Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...
If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.
While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...